Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 16Observational 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 8Carcinoma, Ovarian Epithelial 3Neoplasms 2Fallopian Tube Neoplasms 2Kenny-Caffey syndrome, Type 1 1Carcinoma 1Advanced Ovarian Cancer 1

Interventions

Surveys and Questionnaires 5niraparib 2Polymerase Chain Reaction 2Immunohistochemistry 2Geriatric Assessment 2Gene Expression Profiling 2Flow Cytometry 2Blood Specimen Collection 2rucaparib 1Tissue Banks 1Taxes 1Sutures 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Ropivacaine 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Paracentesis 1Papanicolaou Test 1Paclitaxel 1Observation 1Neuroimaging 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Mitomycin 1Microarray Analysis 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Fallopian Tube Neoplasms × niraparib × Clear all
NCT04295577 2026-05-13

MONITOR-UK

Royal Marsden NHS Foundation Trust

Completed
388 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04546373 2021-08-05

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Grupo Español de Investigación en Cáncer de Ovario

Completed
316 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡